PYRAZOLDERIVATE ALS STING-AGONISTEN

Patent europeic · EP4526298 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4526298
Numer da la dumonda
EP23727300
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-05-2023
Publitgà
26-03-2025
Concedì
28-10-2026
La protecziun finescha il pli tard
15-05-2043
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07D 401/14 (2006.01)
C07D 487/04 (2006.01)
A61K 31/4155 (2006.01)
A61P 35/00 (2006.01)
Prioritad
WO PCT/CN2022/093600 18.05.2022
WO PCT/CN2022/124648 11.10.2022
WO PCT/CN2023/080862 10.03.2023
WO PCT/CN2023/087630 11.04.2023
Dumonda PCT
PCT/EP2023/063042 16.05.2023
Publicaziun PCT
WO2023/222644 23.11.2023
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 28-10-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 28.10.2026

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstraße 124, 4070 Basel

Inventur

LIU, Haixia

Shanghai 201203, CN

LIU, Yafei

Shanghai 201203, CN

WANG, Jianping

Shanghai 201203, CN

WU, Yao

Shanghai 201203, CN

ZHANG, Zhiwei

Shanghai 201203, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.